STS专家共识(2026):非小细胞肺癌亚肺叶切除的定义与实践
美国胸外科医师学会基于改良德尔菲法组织专家组,围绕早期非小细胞肺癌亚肺叶切除的7个争议领域进行三轮投票,达成21条共识声明,为临床选择手术方式提供指导。
要点
- 近期随机试验显示亚肺叶切除在≤2 cm淋巴结阴性NSCLC中不劣于肺叶切除。
- 共识覆盖7个争议领域,经三轮投票达成21条声明。
- 共识旨在指导早期肺癌中亚肺叶切除的合理应用。
核心结论
- 尽管近期随机试验结果支持亚肺叶切除,早期非小细胞肺癌的亚肺叶切除仍存在多个关键问题,共识声明为临床医生选择不同手术方式提供进一步指导。
研究设计与样本
- 美国胸外科医师学会循证外科工作组组建具有临床和方法学专业知识的胸外科医生专家组,审查现有文献,采用改良德尔菲法,预先确定边界和阈值,直至声明达到75%同意。
主要发现
- 专家组确定了7个关键争议领域。
- 需要三轮投票才在21条声明上达到超过75%的同意,以帮助指导早期肺癌中亚肺叶切除的合理使用。
关键数值与推荐
- 近期两项随机临床试验显示,在≤2 cm且淋巴结阴性的非小细胞肺癌中,亚肺叶切除不劣于肺叶切除。
- 共识声明在21条声明上达到超过75%的同意。
临床怎么用
- 临床医生在考虑早期非小细胞肺癌的不同手术选项时,可参考这些共识声明指导亚肺叶切除的合理应用。
局限性
- 尽管有近期随机临床试验结果,关于早期非小细胞肺癌亚肺叶切除仍存在多个关键问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Two recent randomized clinical trials have shown sublobar resection to be noninferior to lobectomy in node-negative non-small cell lung cancer ≤2 cm. As a result, the use of sublobar resection in early lung cancer patients has significantly increased. Consensus recommendations are needed to guide its appropriate use. METHODS: The Society of Thoracic Surgeons Workforce on Evidence-Based Surgery assembled a panel of thoracic surgeons with clinical and methodological expertise to review the existing literature on this topic. A modified Delphi method, with boundaries and thresholds determined a priori, was used until 75% agreement on the statements was reached. RESULTS: The panel identified 7 key areas of controversy. Three rounds of voting were required to reach >75% agreement on 21 statements to help guide appropriate use of sublobar resection in early-stage lung cancer. CONCLUSIONS: Despite results of recent randomized clinical trials, several key questions remain regarding sublobar resection for early-stage non-small cell lung cancer. These statements will provide further guidance for clinicians considering the different surgical options.
引用
- Khullar OV, Kidane B, Altorki N, et al. The Society of Thoracic Surgeons Expert Consensus Document (2026) on Addressing Definition and Practices of Sublobar Resection in Non-Small Cell Lung Cancer. Ann Thorac Surg. 2026. PMID: 42320552. doi:10.1016/j.athoracsur.2026.06.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。